PD‐L1 in Ovarian Cancer: Immune Evasion, Tumor‐Intrinsic Signaling, and Chemoresistance
This review synthesizes emerging evidence that extends the role of PD‐L1 beyond canonical immune evasion to include tumor‐cell‐intrinsic mechanisms that may contribute to chemoresistance and provides a rationale for combination strategies targeting both immune escape and tumor‐intrinsic resistance mechanisms.